Click for best price
Opioid Induced Constipation Drugs Market Size, Share 2022
Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market
The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Induced Constipation Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Induced Constipation Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Induced Constipation Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Induced Constipation Drugs market.
Global Opioid Induced Constipation Drugs Scope and Market Size
Opioid Induced Constipation Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Opioid Induced Constipation Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Segment by Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
By Company
- Ironwood Pharmaceuticals Inc
- Daiichi Sankyo Co Ltd
- Pfizer
- Progenics Pharmaceuticals Inc
- Shionogi & Co., Ltd
- Allergan Plc
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma AG
- Mundipharma International Limited
- Ono Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma Inc
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Opioid Induced Constipation Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Opioid Induced Constipation Drugs, with price, sales, revenue, and global market share of Opioid Induced Constipation Drugs from 2019 to 2022.
Chapter 3, the Opioid Induced Constipation Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Opioid Induced Constipation Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioid Induced Constipation Drugs.
Chapter 13, 14, and 15, to describe Opioid Induced Constipation Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Opioid Induced Constipation Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Opioid Induced Constipation Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Opioid Induced Constipation Drugs Product Introduction
1.2 Global Opioid Induced Constipation Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Opioid Induced Constipation Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Opioid Induced Constipation Drugs Sales in Volume for the Year 2017-2028
1.3 United States Opioid Induced Constipation Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Opioid Induced Constipation Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Opioid Induced Constipation Drugs Sales in Volume for the Year 2017-2028
1.4 Opioid Induced Constipation Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Opioid Induced Constipation Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Opioid Induced Constipation Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Opioid Induced Constipation Drugs Market Dynamics
1.5.1 Opioid Induced Constipation Drugs Industry Trends
1.5.2 Opioid Induced Constipation Drugs Market Drivers
1.5.3 Opioid Induced Constipation Drugs Market Challenges
1.5.4 Opioid Induced Constipation Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Opioid Induced Constipation Drugs Market Segment by Type
2.1.1 Lubiprostone
2.1.2 Methyl Naltrexone Bromide
2.1.3 Naldemedine
2.1.4 Alvimopan
2.1.5 Others
2.2 Global Opioid Induced Constipation Drugs Market Size by Type
2.2.1 Global Opioid Induced Constipation Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Opioid Induced Constipation Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Opioid Induced Constipation Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Opioid Induced Constipation Drugs Market Size by Type
2.3.1 United States Opioid Induced Constipation Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Opioid Induced Constipation Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Opioid Induced Constipation Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Opioid Induced Constipation Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Opioid Induced Constipation Drugs Market Size by Application
3.2.1 Global Opioid Induced Constipation Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Opioid Induced Constipation Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Opioid Induced Constipation Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Opioid Induced Constipation Drugs Market Size by Application
3.3.1 United States Opioid Induced Constipation Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Opioid Induced Constipation Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Opioid Induced Constipation Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Opioid Induced Constipation Drugs Competitor Landscape by Company
4.1 Global Opioid Induced Constipation Drugs Market Size by Company
4.1.1 Top Global Opioid Induced Constipation Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Opioid Induced Constipation Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Opioid Induced Constipation Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Opioid Induced Constipation Drugs Price by Manufacturer (2017-2022)
4.2 Global Opioid Induced Constipation Drugs Concentration Ratio (CR)
4.2.1 Opioid Induced Constipation Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Opioid Induced Constipation Drugs in 2021
4.2.3 Global Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Opioid Induced Constipation Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Opioid Induced Constipation Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Opioid Induced Constipation Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Opioid Induced Constipation Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Opioid Induced Constipation Drugs Market Size by Company
4.5.1 Top Opioid Induced Constipation Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Opioid Induced Constipation Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Opioid Induced Constipation Drugs Sales by Players (2020, 2021 & 2022)
5 Global Opioid Induced Constipation Drugs Market Size by Region
5.1 Global Opioid Induced Constipation Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Opioid Induced Constipation Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Opioid Induced Constipation Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Opioid Induced Constipation Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Opioid Induced Constipation Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Opioid Induced Constipation Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Opioid Induced Constipation Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Opioid Induced Constipation Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Opioid Induced Constipation Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Opioid Induced Constipation Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Opioid Induced Constipation Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Opioid Induced Constipation Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Opioid Induced Constipation Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Opioid Induced Constipation Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Opioid Induced Constipation Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Opioid Induced Constipation Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Opioid Induced Constipation Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Corporation Information
7.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Products Offered
7.1.5 Ironwood Pharmaceuticals Inc Recent Development
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Corporation Information
7.2.2 Daiichi Sankyo Co Ltd Description and Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Products Offered
7.2.5 Daiichi Sankyo Co Ltd Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Opioid Induced Constipation Drugs Products Offered
7.3.5 Pfizer Recent Development
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Corporation Information
7.4.2 Progenics Pharmaceuticals Inc Description and Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Products Offered
7.4.5 Progenics Pharmaceuticals Inc Recent Development
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Corporation Information
7.5.2 Shionogi & Co., Ltd Description and Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Products Offered
7.5.5 Shionogi & Co., Ltd Recent Development
7.6 Allergan Plc
7.6.1 Allergan Plc Corporation Information
7.6.2 Allergan Plc Description and Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allergan Plc Opioid Induced Constipation Drugs Products Offered
7.6.5 Allergan Plc Recent Development
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Corporation Information
7.7.2 Nektar Therapeutics Description and Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Nektar Therapeutics Opioid Induced Constipation Drugs Products Offered
7.7.5 Nektar Therapeutics Recent Development
7.8 Purdue Pharma
7.8.1 Purdue Pharma Corporation Information
7.8.2 Purdue Pharma Description and Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Purdue Pharma Opioid Induced Constipation Drugs Products Offered
7.8.5 Purdue Pharma Recent Development
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Corporation Information
7.9.2 S.L.A. Pharma AG Description and Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Products Offered
7.9.5 S.L.A. Pharma AG Recent Development
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Corporation Information
7.10.2 Mundipharma International Limited Description and Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Products Offered
7.10.5 Mundipharma International Limited Recent Development
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
7.11.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Products Offered
7.11.5 Ono Pharmaceutical Co., Ltd Recent Development
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporation Information
7.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Takeda Pharmaceutical Company Limited Products Offered
7.12.5 Takeda Pharmaceutical Company Limited Recent Development
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Corporation Information
7.13.2 Theravance Biopharma Inc Description and Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Theravance Biopharma Inc Products Offered
7.13.5 Theravance Biopharma Inc Recent Development
7.14 Bausch Health
7.14.1 Bausch Health Corporation Information
7.14.2 Bausch Health Description and Business Overview
7.14.3 Bausch Health Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Bausch Health Products Offered
7.14.5 Bausch Health Recent Development
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Corporation Information
7.15.2 Cosmo Pharmaceuticals SA Description and Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Cosmo Pharmaceuticals SA Products Offered
7.15.5 Cosmo Pharmaceuticals SA Recent Development
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Corporation Information
7.16.2 Daewoong Pharmaceutical Description and Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Daewoong Pharmaceutical Products Offered
7.16.5 Daewoong Pharmaceutical Recent Development
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Corporation Information
7.17.2 C.B. Fleet Company Description and Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 C.B. Fleet Company Products Offered
7.17.5 C.B. Fleet Company Recent Development
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Corporation Information
7.18.2 Sucampo Pharmaceuticals Description and Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Sucampo Pharmaceuticals Products Offered
7.18.5 Sucampo Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Opioid Induced Constipation Drugs Industry Chain Analysis
8.2 Opioid Induced Constipation Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Opioid Induced Constipation Drugs Distributors
8.3 Opioid Induced Constipation Drugs Production Mode & Process
8.4 Opioid Induced Constipation Drugs Sales and Marketing
8.4.1 Opioid Induced Constipation Drugs Sales Channels
8.4.2 Opioid Induced Constipation Drugs Distributors
8.5 Opioid Induced Constipation Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Opioid Induced Constipation Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Opioid Induced Constipation Drugs Market Trends
Table 3. Opioid Induced Constipation Drugs Market Drivers
Table 4. Opioid Induced Constipation Drugs Market Challenges
Table 5. Opioid Induced Constipation Drugs Market Restraints
Table 6. Global Opioid Induced Constipation Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Opioid Induced Constipation Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Opioid Induced Constipation Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Opioid Induced Constipation Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Opioid Induced Constipation Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Opioid Induced Constipation Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Opioid Induced Constipation Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Opioid Induced Constipation Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Opioid Induced Constipation Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Opioid Induced Constipation Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Opioid Induced Constipation Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Opioid Induced Constipation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation Drugs as of 2021)
Table 18. Top Players of Opioid Induced Constipation Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Opioid Induced Constipation Drugs Product Type
Table 20. Date of International Manufacturers Enter into Opioid Induced Constipation Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Opioid Induced Constipation Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Opioid Induced Constipation Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Opioid Induced Constipation Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Opioid Induced Constipation Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Opioid Induced Constipation Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Opioid Induced Constipation Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Opioid Induced Constipation Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Opioid Induced Constipation Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Opioid Induced Constipation Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Opioid Induced Constipation Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Opioid Induced Constipation Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Opioid Induced Constipation Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Opioid Induced Constipation Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Opioid Induced Constipation Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Opioid Induced Constipation Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Opioid Induced Constipation Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Opioid Induced Constipation Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Opioid Induced Constipation Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Opioid Induced Constipation Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Opioid Induced Constipation Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Ironwood Pharmaceuticals Inc Corporation Information
Table 43. Ironwood Pharmaceuticals Inc Description and Business Overview
Table 44. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product
Table 46. Ironwood Pharmaceuticals Inc Recent Development
Table 47. Daiichi Sankyo Co Ltd Corporation Information
Table 48. Daiichi Sankyo Co Ltd Description and Business Overview
Table 49. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Daiichi Sankyo Co Ltd Product
Table 51. Daiichi Sankyo Co Ltd Recent Development
Table 52. Pfizer Corporation Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Pfizer Product
Table 56. Pfizer Recent Development
Table 57. Progenics Pharmaceuticals Inc Corporation Information
Table 58. Progenics Pharmaceuticals Inc Description and Business Overview
Table 59. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Progenics Pharmaceuticals Inc Product
Table 61. Progenics Pharmaceuticals Inc Recent Development
Table 62. Shionogi & Co., Ltd Corporation Information
Table 63. Shionogi & Co., Ltd Description and Business Overview
Table 64. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Shionogi & Co., Ltd Product
Table 66. Shionogi & Co., Ltd Recent Development
Table 67. Allergan Plc Corporation Information
Table 68. Allergan Plc Description and Business Overview
Table 69. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Allergan Plc Product
Table 71. Allergan Plc Recent Development
Table 72. Nektar Therapeutics Corporation Information
Table 73. Nektar Therapeutics Description and Business Overview
Table 74. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Nektar Therapeutics Product
Table 76. Nektar Therapeutics Recent Development
Table 77. Purdue Pharma Corporation Information
Table 78. Purdue Pharma Description and Business Overview
Table 79. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Purdue Pharma Product
Table 81. Purdue Pharma Recent Development
Table 82. S.L.A. Pharma AG Corporation Information
Table 83. S.L.A. Pharma AG Description and Business Overview
Table 84. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. S.L.A. Pharma AG Product
Table 86. S.L.A. Pharma AG Recent Development
Table 87. Mundipharma International Limited Corporation Information
Table 88. Mundipharma International Limited Description and Business Overview
Table 89. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Mundipharma International Limited Product
Table 91. Mundipharma International Limited Recent Development
Table 92. Ono Pharmaceutical Co., Ltd Corporation Information
Table 93. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 94. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Ono Pharmaceutical Co., Ltd Product
Table 96. Ono Pharmaceutical Co., Ltd Recent Development
Table 97. Takeda Pharmaceutical Company Limited Corporation Information
Table 98. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 99. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Takeda Pharmaceutical Company Limited Product
Table 101. Takeda Pharmaceutical Company Limited Recent Development
Table 102. Theravance Biopharma Inc Corporation Information
Table 103. Theravance Biopharma Inc Description and Business Overview
Table 104. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Theravance Biopharma Inc Product
Table 106. Theravance Biopharma Inc Recent Development
Table 107. Bausch Health Corporation Information
Table 108. Bausch Health Description and Business Overview
Table 109. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Bausch Health Product
Table 111. Bausch Health Recent Development
Table 112. Cosmo Pharmaceuticals SA Corporation Information
Table 113. Cosmo Pharmaceuticals SA Description and Business Overview
Table 114. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Cosmo Pharmaceuticals SA Product
Table 116. Cosmo Pharmaceuticals SA Recent Development
Table 117. Daewoong Pharmaceutical Corporation Information
Table 118. Daewoong Pharmaceutical Description and Business Overview
Table 119. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Daewoong Pharmaceutical Product
Table 121. Daewoong Pharmaceutical Recent Development
Table 122. C.B. Fleet Company Corporation Information
Table 123. C.B. Fleet Company Description and Business Overview
Table 124. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. C.B. Fleet Company Product
Table 126. C.B. Fleet Company Recent Development
Table 127. Sucampo Pharmaceuticals Corporation Information
Table 128. Sucampo Pharmaceuticals Description and Business Overview
Table 129. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Sucampo Pharmaceuticals Product
Table 131. Sucampo Pharmaceuticals Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Opioid Induced Constipation Drugs Customers List
Table 135. Opioid Induced Constipation Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid Induced Constipation Drugs Product Picture
Figure 2. Global Opioid Induced Constipation Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Opioid Induced Constipation Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Opioid Induced Constipation Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Opioid Induced Constipation Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Opioid Induced Constipation Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Opioid Induced Constipation Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Opioid Induced Constipation Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Opioid Induced Constipation Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Opioid Induced Constipation Drugs Report Years Considered
Figure 11. Product Picture of Lubiprostone
Figure 12. Product Picture of Methyl Naltrexone Bromide
Figure 13. Product Picture of Naldemedine
Figure 14. Product Picture of Alvimopan
Figure 15. Product Picture of Others
Figure 16. Global Opioid Induced Constipation Drugs Market Share by Type in 2022 & 2028
Figure 17. Global Opioid Induced Constipation Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Opioid Induced Constipation Drugs Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Opioid Induced Constipation Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global Opioid Induced Constipation Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Opioid Induced Constipation Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States Opioid Induced Constipation Drugs Market Share by Type in 2022 & 2028
Figure 23. United States Opioid Induced Constipation Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Opioid Induced Constipation Drugs Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Opioid Induced Constipation Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States Opioid Induced Constipation Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Opioid Induced Constipation Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Product Picture of Retail Pharmacies
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Opioid Induced Constipation Drugs Market Share by Application in 2022 & 2028
Figure 32. Global Opioid Induced Constipation Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Opioid Induced Constipation Drugs Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Opioid Induced Constipation Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 35. Global Opioid Induced Constipation Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Opioid Induced Constipation Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 37. United States Opioid Induced Constipation Drugs Market Share by Application in 2022 & 2028
Figure 38. United States Opioid Induced Constipation Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Opioid Induced Constipation Drugs Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Opioid Induced Constipation Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 41. United States Opioid Induced Constipation Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Opioid Induced Constipation Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Opioid Induced Constipation Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 44. North America Opioid Induced Constipation Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Opioid Induced Constipation Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. Europe Opioid Induced Constipation Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Opioid Induced Constipation Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 55. Asia-Pacific Opioid Induced Constipation Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Opioid Induced Constipation Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 67. Latin America Opioid Induced Constipation Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Opioid Induced Constipation Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 72. Middle East & Africa Opioid Induced Constipation Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. U.A.E Opioid Induced Constipation Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Opioid Induced Constipation Drugs Value Chain
Figure 77. Opioid Induced Constipation Drugs Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
